Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

23/09/2020 STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline 21/09/2020 TIDieR-Placebo: a guide and checklist for reporting placebo and sham controls 09/09/2020 Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension 17/07/2020 The IDEAL Reporting Guidelines: A Delphi Consensus Statement Stage specific recommendations for reporting the evaluation of surgical innovation 22/06/2020 The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design 13/05/2020 Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist) 13/05/2020 PRIRATE 2020 guidelines for reporting randomized trials in Endodontics: a consensus-based development 28/02/2020 Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018) 21/02/2020 Standards for reporting interventions in clinical trials of cupping (STRICTOC): extending the CONSORT statement 10/10/2019 CONSORT extension for reporting N-of-1 trials for traditional Chinese medicine (CENT for TCM): Recommendations, explanation and elaboration

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More